Rutgers University has a strong track record of research, discovery, and innovation, that improves people’s lives. State-of-the-art core facilities and services available for Rutgers’ researchers and industry partners have sparked economic growth at companies like PTC Therapeutics, Inc.
PTC Therapeutics, Inc. focuses on developing and commercializing innovative therapies for rare genetic disorders and other diseases with high unmet medical needs. The company’s foundation stems from a novel, targeted approach towards drug discovery, which was developed through research supported by the National Institutes of Health.
PTC Therapeutics has made a significant economic impact since its inception. The company has created over 200 jobs, many of which are located in the central New Jersey region. In 2023, PTC Therapeutics reported total revenues of $938 million, representing 34% year-over-year growth. PTC has expanded its global reach with products available in multiple countries and ongoing clinical trials worldwide.
Rutgers University’s research and innovation ecosystem has achieved remarkable heights with its extensive network of over 300 research centers and institutes driving groundbreaking discoveries. This robust infrastructure supports a diverse portfolio of more than 1,300 active patents worldwide and has fostered the creation of over 100 startups tackling complex societal challenges. The university’s collaboration with industry partners, such as PTC Therapeutics, has significantly contributed to economic growth in the region.
Rutgers’ research initiatives are pivotal in stimulating job creation and economic development, particularly in central New Jersey. As Rutgers continues to expand its research capabilities and partnerships, it is poised to further enhance its role as a driver of economic growth and innovation in New Jersey.